WO2009128088A3 - Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin - Google Patents
Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin Download PDFInfo
- Publication number
- WO2009128088A3 WO2009128088A3 PCT/IN2008/000725 IN2008000725W WO2009128088A3 WO 2009128088 A3 WO2009128088 A3 WO 2009128088A3 IN 2008000725 W IN2008000725 W IN 2008000725W WO 2009128088 A3 WO2009128088 A3 WO 2009128088A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ethylamine
- preparation
- tamsulosin
- carvedilol
- phenoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present patent application relates to a process for the preparation of 2-(2-Alkoxy phenoxy) ethylamine or a salt thereof, which is a useful intermediate in the preparation of several active pharmaceutical ingredients including Carvedilol and Tamsulosin. It also provides 2-(2-methoxy phenoxy) ethylamine in solid form.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN923/CHE/2008 | 2008-04-15 | ||
IN923CH2008 | 2008-04-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009128088A2 WO2009128088A2 (en) | 2009-10-22 |
WO2009128088A3 true WO2009128088A3 (en) | 2010-12-23 |
Family
ID=41199536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000725 WO2009128088A2 (en) | 2008-04-15 | 2008-11-03 | Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009128088A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109206328A (en) * | 2018-09-27 | 2019-01-15 | 铜仁学院 | A kind of preparation method of 2- (2- methoxyphenoxy) ethamine |
CN115232034B (en) * | 2022-07-29 | 2024-02-20 | 上药康丽(常州)药业有限公司 | Synthesis method of tamsulosin hydrochloride |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999051576A1 (en) * | 1998-04-08 | 1999-10-14 | American Home Products Corporation | N-aryloxyethylamine derivatives for the treatment of depression |
US20010056211A1 (en) * | 1997-07-31 | 2001-12-27 | Ing-Jun Chen | Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity |
-
2008
- 2008-11-03 WO PCT/IN2008/000725 patent/WO2009128088A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010056211A1 (en) * | 1997-07-31 | 2001-12-27 | Ing-Jun Chen | Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity |
WO1999051576A1 (en) * | 1998-04-08 | 1999-10-14 | American Home Products Corporation | N-aryloxyethylamine derivatives for the treatment of depression |
Non-Patent Citations (3)
Title |
---|
A.M. LIU ET AL, SYNTHESIS OF 2-(2-METHOXYPHENOXY)ETHYLAMINE, pages 794 - 796 * |
CHEN, WEIMIN ET AL: "Synthesis of 2-(2- methoxyphenoxy)ethylamine by phase transfer catalysis and microwave radiation", HUAXUE SHIJIE, vol. 39, no. 2, 1998, pages 86 - 87 * |
N.I. PEIZHOU ET AL, SYNTHESIS OF 2-(2-METHOXYPHENOXY)ETHYLAMINE, pages 321 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009128088A2 (en) | 2009-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0910758A2 (en) | thermostable solid composition, pharmaceutical composition, processes for preparing a thermostable solid composition and a pharmaceutical composition, method for improving the bioavailability of a pharmaceutically active ingredient, and | |
EP2769976B8 (en) | Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof | |
ZA200809790B (en) | Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c,lower ldl-c and lower cholesterol | |
EP2273975B8 (en) | Pharmaceutical solutions, process of preparation and therapeutic uses | |
WO2011161226A3 (en) | Novel antibody formulation | |
WO2008132229A3 (en) | Highly concentrated insulin solutions and compositions | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
WO2010031720A3 (en) | Novel antibody formulation | |
WO2009135593A3 (en) | Solid pharmaceutical formulation with delayed release | |
EP2816035A3 (en) | Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction | |
WO2012017323A3 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv | |
WO2008092219A3 (en) | Pharmaceutical composition comprising tramadol and ketoprofen | |
WO2011056785A3 (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
WO2009128088A3 (en) | Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin | |
EA200900463A1 (en) | ARIPIPRAZOLA HEMIFUMARAT AND METHOD FOR ITS OBTAINING | |
BRPI0712346B8 (en) | process to produce solid pharmaceutical powder of tmc125, solid dispersion and its pharmaceutical formulation | |
EP2335698B8 (en) | Pharmaceutical solid preparation having active ingredients separated by boundary therein | |
WO2011127244A8 (en) | ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT | |
MX349563B (en) | Pharmaceutical formulation of nanonised fenofibrate. | |
WO2010046865A3 (en) | Ophthalmic administration of a composition including brimonidine as a mist | |
JP2009292763A5 (en) | ||
FR2903602B1 (en) | INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME | |
WO2007025764A3 (en) | Pharmaceutical formulations for salts of monobasic acids comprising clopidogrel | |
WO2012150607A3 (en) | Oral liquid composition comprising divalproex sodium and process for preparing thereof | |
WO2010142143A9 (en) | Pirfenidone compound, preparation method and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08873943 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08873943 Country of ref document: EP Kind code of ref document: A2 |